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Patrick Hickey, DO, Rohit Sharma, MD, Shanth Goonewardene, MD, Shashin Shah, MD and Hiral Shah, MD
Lehigh Valley Health Network, Allentown, PA

Background

Discussion

•	Neurofibromatosis type 1 (NF1) is an autosomal dominant hereditary tumor syndrome
•	Increased risk of GI tumors including neurofibromas, GISTs, and periampullary carcinoids is reported
•	Periampullary somatostatinomas as well as true neurogenic tumors including extra-adrenal pheochromocytomas
(paragangliomas) and ganglioneuromas have also been reported
•	This case study reviews a patient with NF1 and multiple intra-abdominal neoplasms

•	Alterations in the NF1 gene (tumor suppressor) encodes for the protein neurofibromin
•	Unlike sporadic GISTs, NF1 associated GISTs do not usually harbor c-KIT or PDGFRA
mutations
•	Pheochromocytomas reportedly affect 0.1-6% of NF1 patients. 3/14 reported cases of
composite pheochromocytoma-ganglioneuroma were associated with NF1
•	The combination of pheochromocytoma and GIST has been described in 14 NF1 cases
•	Periampullary tumors in NF1 patients are most commonly carcinoid, but most do not
develop somatostatinoma syndrome
•	To our knowledge this if the first case of a patient with NF1 diagnosed with ampullary
somatostatinoma, small bowel GISTs, and extra-adrenal composite pheochromocytomaganglioneuroma occurring together

Initial Case Description
•	A 32 year old male presented with six months of jaundice, dark urine, and weight loss
•	CT: dilated intrahepatic ducts, and elevated bilirubin and ALP
•	ERCP with biopsy of the ampulla: invasive malignancy with neuroendocrine differentiation
•	Pancreaticoduodenectomy showed low-grade somatostatinoma of the ampulla and an incidental duodenal GIST

Case Continuation
•	CT scan at year two found an enlarging upper abdominal mass concerning for nodal metastasis
•	Ex-lap removal found a paraganglioma in association with ganglioneuroma
•	Given the pathology, the diagnosis of NF1 was confirmed with mutation analysis showing a truncating mutation
in NF1
•	His exam showed multiple café au lait spots on the trunk and upper extremities, multiple neurofibromas, and
axillary freckling
•	Years later he had a progressive right adrenal nodule and elevated plasma/urine metanephrines
•	Resection of a paracaval functional paraganglioma and partial right adrenalectomy with postoperative XRT to the
right adrenal bed was performed
•	One year later, CT and OctreoScan showed a tumor corresponding with nodularity in the jejunal limb and
pancreaticobiliary anastomosis
•	Surgery confirmed proximal and distal jejunal GISTs
•	Systemic octreotide treatment is under consideration

Figure 1: Paraganglioma Intermediate Power.

Figure 2: Paranglioma High Power.
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